Hong Fan

Dr. Hong Fan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025 in Clinical Nutrition
Verified
Journal Article
Closed access
HFHong Fan
Hong Fan
MKMatina Kouvari
Matina Kouvari
CGChengnan Guo
Chengnan Guo
ZLZhenqiu Liu
Zhenqiu Liu
XZXin Zhang
Xin Zhang
CMChristos S. Mantzoros
Christos S. Mantzoros

27 June 2024 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
XYXinyu Yang
Xinyu Yang
HYHao Yin
Hao Yin
SZShaoyuan Zhang
Shaoyuan Zhang
TJTian Jiang
Tian Jiang
JGJianmin Gu
Jianmin Gu
LTLijie Tan
Lijie Tan

23 February 2024 in JGH Open
Verified
Journal Article
Open access
SWShuo Wang
Shuo Wang
DXDing Xia
Ding Xia
HFHong Fan
Hong Fan
ZLZhenqiu Liu
Zhenqiu Liu
RCRuilin Chen
Ruilin Chen
TZTiejun Zhang
Tiejun Zhang
Background and Aim: Metabolic dysfunction‐associated steatotic liver disease (MASLD) is recently introduced to better highlight the pathogenic significance of cardiometabolic dysfunction, as compared with non‐alcoholic fatty liver disease. This study aimed to investigate the association between low thyroid function and MASLD in the new context.Methods: We recruited 2901 participants for our retrospective cohort study from 2016 to 2021. Participants were divided into strict‐normal thyroid function and low thyroid function groups (low‐normal thyroid function, subclinical hypothyroidism) based on initial thyroid stimulating hormone (TSH) levels, respectively. Cox regression models were used to estimate the hazard ratios (HRs) and 95% CI.Results: During a median follow‐up of 15.6 months, 165 (8.9%) strict‐normal thyroid function subjects and 141 (13.4%) low thyroid function subjects developed MASLD; this result was statistically relevant (P < 0.05). Univariate regression analysis showed that low thyroid function and subclinical hypothyroidism were statistically significantly associated with MASLD (low thyroid function: HR1.53; 95% CI 1.22–1.92; subclinical hypothyroidism: HR1.95; 95% CI 1.47–2.60).Conclusions: MASLD is associated with low thyroid function and the relationship between MASLD and low thyroid function is independent.

17 January 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
SZShi-Jie Zhang
Shi-Jie Zhang
XTXiang Tong
Xiang Tong
TZTianli Zhang
Tianli Zhang
DWDongguang Wang
Dongguang Wang
SLSitong Liu
Sitong Liu
HFHong Fan
Hong Fan
Background: Sarcoidosis-associated pulmonary hypertension (SAPH) is associated with poor prognosis, conferring up to a 10-fold increase in mortality in patients with sarcoidosis, but the actual prevalence of SAPH is unknown.Methods: The PubMed, Embase, and Cochrane Library databases were systematically searched for epidemiological studies reporting the prevalence of SAPH up to July 2021. Two reviewers independently performed the study selection, data extraction, and quality assessment. Studies were pooled using random-effects meta-analysis.Results: This meta-analysis included 25 high-quality studies from 12 countries, with a pooled sample of 632,368 patients with sarcoidosis. The prevalence of SAPH by transthoracic echocardiography in Europe, the United States and Asia was 18.8% [95% confidence interval (CI): 11.1–26.5%], 13.9% (95% CI: 5.4–22.4%) and 16.2% (95% CI: 7.1–25.4%) separately, and the overall pooled prevalence was 16.4% (95%CI: 12.2–20.5%). By right heart catheterization (RHC), the pooled prevalence of SAPH was 6.4% (95% CI: 3.6–9.1%) in general sarcoidosis population, and subgroup analyses showed that the prevalence of SAPH was 6.7% (95% CI: 2.4–11.0%) in Europe and 8.6% (95% CI: −4.1 to 21.3%) in the United States. Further, the prevalence of pre-capillary PH was 6.5% (95% CI: 2.9–10.2%). For the population with advanced sarcoidosis, the pooled prevalence of SAPH and pre-capillary PH by RHC was as high as 62.3% (95% CI: 46.9–77.6%) and 55.9% (95% CI: 20.1–91.7%), respectively. Finally, the pooled prevalence of SAPH in large databases with documented diagnoses (6.1%, 95% CI: 2.6–9.5%) was similar to that of RHC. Substantial heterogeneity across studies was observed for all analyses (I2 > 80%, P < 0.001).Conclusions: The sarcoidosis population has a relatively low burden of PH, mainly pre-capillary PH. However, as the disease progresses to advanced sarcoidosis, the prevalence of SAPH increases significantly.

11 December 2024 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
HFHong Fan
Hong Fan
MKMatina Kouvari
Matina Kouvari
GMGeltrude Mingrone
Geltrude Mingrone
JGJacob George
Jacob George
GPGeorgios Papatheodoridis
Georgios Papatheodoridis
CMChristos S. Mantzoros
Christos S. Mantzoros

17 December 2022 in Digestive and Liver Disease
Verified
Journal Article
Closed access
HFHong Fan
Hong Fan
LLLili Li
Lili Li
ZLZhenqiu Liu
Zhenqiu Liu
LCLiou Cao
Liou Cao
XCXingdong Chen
Xingdong Chen
TZTiejun Zhang
Tiejun Zhang